Dr. Siddhartha Mukherjee
MD, DPhil
Haematologist-Oncologist & Cancer Researcher
corporate_fareColumbia University Irving Medical Center, New York
Siddhartha Mukherjee
MD, DPhil
Dr. Siddhartha Mukherjee is an Indian-born American haematologist-oncologist, cancer researcher and author based at Columbia University in New York. He is associated with the Herbert Irving Comprehensive Cancer Center and NewYork-Presbyterian / Columbia University Irving Medical Center.
His clinical and academic work focuses on medical oncology, blood cancers and the biology of blood development, with a particular research interest in myelodysplastic syndrome and acute myeloid leukaemia. As an Associate Professor of Medicine at Columbia University Vagelos College of Physicians and Surgeons, his laboratory studies the mechanisms behind malignant and pre-malignant blood disorders, with the goal of developing new drugs and therapeutic strategies. He is also widely recognised for making the science of cancer understandable to patients and families through his writing, including the Pulitzer Prize-winning book The Emperor of All Maladies: A Biography of Cancer. In 2023 he was elected to the National Academy of Medicine, and in 2014 he received the Padma Shri from the Government of India.
CancerFax can coordinate medical-report review and second-opinion support for international patients seeking an expert oncology opinion.
Why Consider Dr. Siddhartha Mukherjee?
Dr. Mukherjee brings together the roles of practising oncologist, blood-cancer researcher, academic physician and acclaimed author.
Areas of Specialisation
Haematologic oncology and translational cancer research
Haematologic Malignancies
Clinical expertise in blood and lymphatic cancers.
- arrow_rightAcute myeloid leukaemia (AML)
- arrow_rightMyelodysplastic syndrome (MDS)
- arrow_rightLymphoma evaluation and management
- arrow_rightMultiple myeloma
Translational Cancer Research
Laboratory research bridging cancer biology and the development of new therapies.
- arrow_rightBiology of normal and malignant blood development
- arrow_rightTissue-resident stem-cell research
- arrow_rightDevelopment of novel medicines for acute myeloid leukaemia
- arrow_rightImmunotherapy research approaches for blood cancers
Clinical Services & Approaches
Haematology-oncology care and expert review
Systemic Treatment for Blood Cancers
Medical OncologyTreatment planning for leukaemia, lymphoma, myeloma and myelodysplastic syndrome.
Diagnostic & Molecular Evaluation
DiagnosisAssessment and characterisation of blood and bone-marrow disorders.
Second Opinion Consultations
Second OpinionIndependent expert review for complex haematologic oncology cases.
Research & Publications
Cancer research, drug development and acclaimed authorship
A more detailed publication and research list may be available on request through CancerFax.
Education & Training
Dr. Mukherjee trained at leading institutions in the United States and the United Kingdom.
Clinical Experience
Dr. Mukherjee combines patient care, teaching and cancer research at Columbia University in New York.
Languages & International
Dr. Mukherjee consults in the following language.
CancerFax can coordinate professional medical interpreter support for international patients.
CancerFax can coordinate professional medical interpreter support when required.
How CancerFax Helps You Access Dr. Siddhartha Mukherjee
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Siddhartha Mukherjee's team — with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history — prepared as a structured clinical summary for Dr. Siddhartha Mukherjee's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Siddhartha Mukherjee before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Siddhartha Mukherjee's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Siddhartha Mukherjee's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Siddhartha Mukherjee's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Dr. Siddhartha Mukherjee
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion connected with Dr. Mukherjee or the Columbia oncology team, subject to institutional availability and case acceptance.
Dr. Mukherjee is a haematologist-oncologist whose clinical expertise covers lymphoma, myelodysplastic syndrome and myeloma. His research laboratory focuses on blood development and malignant blood disorders, particularly myelodysplastic syndrome and acute myeloid leukaemia.
He is known for combining clinical oncology with cancer research and science writing. His book The Emperor of All Maladies: A Biography of Cancer won the 2011 Pulitzer Prize for General Nonfiction, and he was elected to the National Academy of Medicine in 2023.
Submit your medical reports through CancerFax. The CancerFax team will review the documents, prepare the case for submission, and coordinate the next steps with the hospital or doctor, subject to availability.
Yes. A second-opinion request can be submitted through CancerFax with the patient's pathology reports, bone-marrow results, imaging, and treatment history. The final consultation format and availability depend on the doctor's institution.
Yes. Dr. Mukherjee leads a research laboratory studying blood development and malignant blood disorders, with work that includes the development of new immunotherapy medicines for acute myeloid leukaemia. CancerFax can help patients explore research-based and trial pathways where these are available and appropriate.
Connect with Siddhartha Mukherjee Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.